
浏览全部资源
扫码关注微信
400016 重庆,重庆医科大学附属第一医院神经外科
[ 霍钢,E-mail:xiaomin198171@tom.com HUO Gang, E-mail: xiaomin198171@tom.com
收稿:2018-10-10,
修回:2018-11-18,
纸质出版:2019-03-30
移动端阅览
陈宸, 陈松, 霍钢. RNAi沉默S100A9对U87胶质瘤干细胞增殖和自我更新的影响[J]. 第三军医大学学报, 2019,41(6):575-580.
Chen CHEN, Song CHEN, Gang HUO. Effect of RNA interference-mediated S100A9 gene silencing on proliferation and self-renewal of U87 glioma stem cells
陈宸, 陈松, 霍钢. RNAi沉默S100A9对U87胶质瘤干细胞增殖和自我更新的影响[J]. 第三军医大学学报, 2019,41(6):575-580. DOI: 10.16016/j.1000-5404.201810047.
Chen CHEN, Song CHEN, Gang HUO. Effect of RNA interference-mediated S100A9 gene silencing on proliferation and self-renewal of U87 glioma stem cells
目的
2
探讨沉默S100A9蛋白对人U87胶质瘤干细胞增殖和自我更新能力的影响和机制。
方法
2
采用shRNA-S100A9慢病毒感染人U87胶质瘤干细胞,RT-qPCR检测S100A9 mRNA表达,Western blot检测S100A9蛋白表达,MTT法检测细胞的增殖情况,干细胞球形成实验检测自我更新能力,RT-qPCR和Western blot检测β-catenin mRNA和蛋白的表达。
结果
2
慢病毒感染后的细胞组S100A9 mRNA和蛋白表达均受到了明显抑制(
P
<
0.05),细胞增殖变慢(
P
<
0.05),干细胞球形成能力受到明显抑制(
P
<
0.05),β-catenin mRNA和蛋白的表达明显下调(
P
<
0.05)。
结论
2
抑制S100A9蛋白的表达能明显抑制U87胶质瘤干细胞增殖和自我更新能力,其机制可能与抑制Wnt/β-catenin信号转导通路有关。
Objective
2
To investigate the effect of S100A9 gene silencing on proliferation and self-renewal ability of human U87 glioma stem cells.
Methods
2
Human U87 glioma stem cells were infected with shRNA-S100A9 lentivirus for S100A9 gene silencing
and the changes in the expression of S100A9 at mRNA and protein levels were analyzed using RT-qPCR and Western blotting
respectively. The changes in the proliferation of the cells were observed using MTT assay
and the self-renewal ability of the stem cells was assessed using stem cell sphere formation assay. The expression of β-catenin at the mRNA and protein levels was detected using RT-qPCR and Western blotting.
Results
2
Infection of U87 cells with shRNA-S100A9 lentivirus caused significant inhibition of the expression of S100A9 at both the mRNA and protein levels (
P
<
0.05) and obviously suppressed the cell proliferation (
P
<
0.05) and stem cell sphere formation (
P
<
0.05). S100A9 gene silencing also significantly down-regulated the mRNA and protein expression of β-catenin in U87 cel
ls (
P
<
0.05).
Conclusion
2
S100A9 gene silencing significantly inhibits the proliferation and self-renewal ability of U87 glioma stem cells
in vitro
.
REARDON D A, RICH J N, FRIEDMAN H S, et al . Recent advances in the treatment of malignant astrocytoma[J ] . J Clin Oncol, 2006, 24(8): 1253-1265. DOI: 10.1200/JCO.2005.04.5302.
CHEN S, ZHAO H, DENG J, et al . Comparative proteomics of glioma stem cells and differentiated tumor cells identifies S100A9 as a potential therapeutic target[J ] . J Cell Biochem, 2013, 114(12): 2795-2808. DOI: 10.1002/jcb.24626.
BAO S, WU Q, MCLENDON R E, et al . Glioma stem cells promote radioresistance by preferential activation of the DNA damage response[J ] . Nature, 2006, 444(7120): 756-760. DOI: 10.1038/nature05236.
ERAMO A, RICCI-VITIANI L, ZEUNER A, et al . Chemotherapy resistance of glioblastoma stem cells[J ] . Cell Death Differ, 2006, 13(7): 1238-1241. DOI: 10.1038/sj.cdd.4401872.
DONATO R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles[J]. Int J Biochem Cell Biol, 2001, 33(7): 637-668. DOI: 10.1016/s1357-2725(01)00046-2.
SALAMA I, MALONE P S, MIHAIMEED F, et al . A review of the S100 proteins in cancer[J ] . Eur J Surg Oncol, 2008, 34(4): 357-364. DOI: 10.1016/j.ejso.2007.04.009.
KIM H J, KANG H J, LEE H, et al . Identification of S100A8 and S100A9 as serological markers for colorectal cancer[J ] . J Proteome Res, 2009, 8(3): 1368-1379. DOI: 10.1021/pr8007573.
PETERSSON S, BYLANDER A, YHR M, et al . S100A7 (Psoriasin), highly expressed in Ductal Carcinoma In Situ(DCIS), is regulated by IFN-gamma in mammary epithelial cells[J ] . BMC Cancer, 2007, 7: 205. DOI: 10.1186/1471-2407-7-205.
WU R, DUAN L, CUI F, et al . S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways[J ] . Exp Cell Res, 2015, 334(2): 228-238. DOI: 10.1016/j.yexcr.2015.04.008.
WU P, QUAN H, KANG J, et al . Downregulation of calcium-binding protein S100A9 inhibits hypopharyngeal cancer cell proliferation and invasion ability through inactivation of NF-κB signaling[J ] . Oncol Res, 2017, 25(9): 1479-1488. DOI: 10.3727/096504017X14886420642823.
CHENG S, ZHANG X, HUANG N, et al . Down-regulation of S100A9 inhibits osteosarcoma cell growth through inactivating MAPK and NF-κB signaling pathways[J ] . BMC Cancer, 2016, 16: 253. DOI: 10.1186/s12885-016-2294-1.
BERGENFELZ C, GABER A, ALLAOUI R, et al . S100A9 expressed in ER(-)PgR(-) breast cancers induces inflammatory cytokines and is associated with an impaired overall survival[J ] . Br J Cancer, 2015, 113(8): 1234-1243. DOI: 10.1038/bjc.2015.346.
ZHANG J, HUANG K, SHI Z, et al . High β-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression[J ] . Neuro Oncology, 2011, 13(6): 600-609. DOI: 10.1093/neuonc/nor034..
WANG Z, CHEN Q. β-catenin knockdown inhibits the proliferation of humanglioma cells in vitro and in vivo [J ] . Exp Ther Med, 2016, 11(3): 1059-1064. DOI: 10.3892/etm.2016.2998..
GONG A, HUANG S. FoxM1 and Wnt/β-catenin signaling in glioma stem cells[J]. Cancer Res, 2012, 72(22): 5658-5662. DOI: 10.1158/0008-5472.CAN-12-0953.
PAUL I, BHATTACHARYA S, CHATTERJEE A, et al . Current understanding on EGFR and Wnt/β-Catenin signaling in glioma and their possible crosstalk[J ] . Genes Cancer, 2013, 4(11/12): 427-446. DOI: 10.1177/1947601913 503341.
FILIPEK A. S100A6 and CacyBP/SIP-two proteins discovered in ehrlich ascites tumor cells that are potentially involved in the degradation of beta-catenin[J]. Chemotherapy, 2006, 52(1): 32-34. DOI: 10.1159/000090240.
NING X, SUN S, ZHANG K, et al . S100A6 protein negatively regulates CacyBP/SIP-mediated inhibition of gastric cancer cell proliferation and tumorigenesis[J ] . PLoS ONE, 2012, 7(1): e30185. DOI: 10.1371/journal.pone.0030185.
DEOL Y S, NASSER M W, YU L, et al . Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells[J ] . J Biol Chem, 2011, 286(52): 44845-44854. DOI: 10.1074/jbc.M111.225466.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621